Loading clinical trials...
Loading clinical trials...
A Study to Evaluate Flash Glucose Monitoring Based Titration of Once-weekly Insulin Icodec in Insulin-naïve Participants With Type 2 Diabetes
This study looks at how a person with type 2 diabetes can be treated with insulin icodec and a flash glucose monitor (a small sensor inserted under the skin to measure blood sugar all the time). The study will look at how well insulin icodec controls blood sugar when used in combination with a flash glucose monitor. Participants will get insulin icodec that they have to inject once a week on the same day of the week. The insulin will be injected with a needle in a skin fold in the thigh, upper arm, or stomach. The study will last for about 8 months. Participants will have to wear a flash glucose monitor throughout the study. This is a sensor that fits on arm. Participants will be asked to use a commercially available app called LibreView to allow team to view flash glucose monitor data. Participants will get a study phone to scan the flash glucose monitor 4 times daily and they will be able to see all of the flash glucose monitor data during the study. Women cannot take part if pregnant, breast-feeding or planning to get pregnant during the study period.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Desert Oasis Hlthcr Med Group
Palm Springs, California, United States
Clinical Trials Research_Sacramento_0
Sacramento, California, United States
San Diego Family Care
San Diego, California, United States
Mills-Peninsula Hlth Services
San Mateo, California, United States
Florida Inst For Clin Res LLC
Orlando, Florida, United States
Metabolic Research Institute Inc
West Palm Beach, Florida, United States
East West Med Res Inst
Honolulu, Hawaii, United States
Northern Pines Hlth Ctr, PC
Buckley, Michigan, United States
International Diabetes Center
Minneapolis, Minnesota, United States
Palm Research Center Inc-Vegas
Las Vegas, Nevada, United States
Start Date
April 11, 2023
Primary Completion Date
March 6, 2024
Completion Date
April 11, 2024
Last Updated
December 2, 2025
51
ACTUAL participants
Insulin Icodec
DRUG
Lead Sponsor
Novo Nordisk A/S
NCT06959901
NCT06574035
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06861062